COVID-19 Medtech Lessons: Data Point To ‘Healthy Industry In An Unhealthy Time’ But Business Models Must Change
Ernst &Young’s annual Pulse of the Industry report says strong R&D spending by medtechs in 2019 bodes well for their post-pandemic recovery as industry leaders point to long-term changes to the industry that companies must navigate when future-proofing their business models.
You may also be interested in...
Johnson & Johnson’s worldwide medical device revenues grew about 50% sequentially in the third quarter to $6.2bn.
IDE trial of SoniVie’s catheter device will be the first for a denervation treatment for PAH.
Move to new distribution center blamed for "very significant" drop in processing capacity for some IVD products.